Shenzhen Salubris Pharmaceuticals Co., Ltd. (SHE: 002294)
China
· Delayed Price · Currency is CNY 34.86
-1.05 (-2.92%)
Oct 11, 2024, 3:04 PM CST
Shenzhen Salubris Pharmaceuticals Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 938.24 | 1,322 | 2,670 | 3,236 | 865.13 | 1,112 | Upgrade
|
| Short-Term Investments | 672.57 | 695.51 | 531.58 | - | - | - | Upgrade
|
| Trading Asset Securities | 533.82 | 186.06 | 328.36 | 60 | 214.59 | 208 | Upgrade
|
| Cash & Short-Term Investments | 2,145 | 2,204 | 3,530 | 3,296 | 1,080 | 1,320 | Upgrade
|
| Cash Growth | -19.01% | -37.58% | 7.12% | 205.25% | -18.20% | 104.61% | Upgrade
|
| Accounts Receivable | 620.43 | 545.38 | 557.72 | 474.03 | 526.57 | 1,166 | Upgrade
|
| Other Receivables | 31 | 21.01 | 23.4 | 155.48 | 30.63 | 31.61 | Upgrade
|
| Receivables | 651.43 | 566.39 | 581.12 | 629.51 | 557.2 | 1,198 | Upgrade
|
| Inventory | 471.82 | 490.86 | 543.53 | 420.45 | 391.56 | 503.15 | Upgrade
|
| Prepaid Expenses | - | - | - | - | 1.13 | - | Upgrade
|
| Other Current Assets | 44.74 | 52.43 | 56.36 | 58 | 102.31 | 68.65 | Upgrade
|
| Total Current Assets | 3,313 | 3,313 | 4,711 | 4,404 | 2,132 | 3,090 | Upgrade
|
| Property, Plant & Equipment | 1,437 | 1,457 | 1,506 | 1,638 | 1,507 | 1,411 | Upgrade
|
| Long-Term Investments | 1,806 | 1,701 | 963.07 | 854.48 | 835.67 | 868.4 | Upgrade
|
| Goodwill | 10.91 | 10.91 | 60.53 | 87.14 | 87.14 | 369.86 | Upgrade
|
| Other Intangible Assets | 1,262 | 1,318 | 965.46 | 1,048 | 1,244 | 1,137 | Upgrade
|
| Long-Term Deferred Tax Assets | 116.2 | 87.4 | 88.42 | 82.01 | 98.26 | 62.98 | Upgrade
|
| Long-Term Deferred Charges | 1,600 | 1,416 | 1,344 | 1,047 | 816.84 | 670.22 | Upgrade
|
| Other Long-Term Assets | 94.97 | 93.31 | 116.64 | 83.09 | 197.43 | 123.97 | Upgrade
|
| Total Assets | 9,640 | 9,397 | 9,755 | 9,244 | 6,918 | 7,733 | Upgrade
|
| Accounts Payable | 145.72 | 156.01 | 219.65 | 187.67 | 223.39 | 144.06 | Upgrade
|
| Accrued Expenses | 584.95 | 491.34 | 558.35 | 487.02 | 327.04 | 353.79 | Upgrade
|
| Short-Term Debt | 10 | 40 | 177.19 | 63 | 300.26 | 124 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | - | - | 60.41 | Upgrade
|
| Current Portion of Leases | 13.21 | 10.93 | 11.46 | 6.99 | - | - | Upgrade
|
| Current Income Taxes Payable | 15.07 | 10.49 | 28.92 | 37.2 | 10.7 | 17.8 | Upgrade
|
| Current Unearned Revenue | 39.93 | 29.55 | 42.66 | 97.99 | 53.23 | 15.29 | Upgrade
|
| Other Current Liabilities | 418.34 | 76.77 | 565.4 | 132.98 | 182.37 | 62.15 | Upgrade
|
| Total Current Liabilities | 1,227 | 815.08 | 1,604 | 1,013 | 1,097 | 777.5 | Upgrade
|
| Long-Term Debt | - | - | - | - | 90 | 158.93 | Upgrade
|
| Long-Term Leases | 4.96 | 12.54 | 19.58 | 9.11 | - | - | Upgrade
|
| Long-Term Unearned Revenue | 90.57 | 84.11 | 98.53 | 93.71 | 89.61 | 84.12 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 22.27 | 13.04 | 27.18 | - | 19.82 | 21.67 | Upgrade
|
| Other Long-Term Liabilities | 423.65 | 416.47 | 29.64 | 82.57 | 30.41 | 24.71 | Upgrade
|
| Total Liabilities | 1,769 | 1,341 | 1,779 | 1,198 | 1,327 | 1,067 | Upgrade
|
| Common Stock | 1,115 | 1,115 | 1,115 | 1,115 | 1,046 | 1,046 | Upgrade
|
| Additional Paid-In Capital | 1,914 | 1,900 | 1,866 | 1,930 | - | 144.36 | Upgrade
|
| Retained Earnings | 5,362 | 5,564 | 5,529 | 5,330 | 4,798 | 5,345 | Upgrade
|
| Treasury Stock | -602.16 | -602.16 | -602.16 | -327.86 | -327.75 | -63.13 | Upgrade
|
| Comprensive Income & Other | 45.07 | 42.22 | 33.24 | -13.41 | -7.69 | 17.15 | Upgrade
|
| Total Common Equity | 7,834 | 8,019 | 7,941 | 8,034 | 5,508 | 6,489 | Upgrade
|
| Minority Interest | 36.73 | 36.43 | 35.81 | 11.91 | 83.33 | 176.92 | Upgrade
|
| Shareholders' Equity | 7,871 | 8,055 | 7,977 | 8,046 | 5,592 | 6,666 | Upgrade
|
| Total Liabilities & Equity | 9,640 | 9,397 | 9,755 | 9,244 | 6,918 | 7,733 | Upgrade
|
| Total Debt | 28.16 | 63.47 | 208.23 | 79.1 | 390.26 | 343.34 | Upgrade
|
| Net Cash (Debt) | 2,116 | 2,140 | 3,322 | 3,217 | 689.46 | 976.61 | Upgrade
|
| Net Cash Growth | -12.69% | -35.58% | 3.28% | 366.56% | -29.40% | 151.66% | Upgrade
|
| Net Cash Per Share | 1.91 | 1.92 | 3.02 | 3.01 | 0.68 | 0.93 | Upgrade
|
| Filing Date Shares Outstanding | 1,091 | 1,091 | 1,091 | 1,103 | 1,029 | 1,035 | Upgrade
|
| Total Common Shares Outstanding | 1,091 | 1,091 | 1,091 | 1,103 | 1,029 | 1,043 | Upgrade
|
| Working Capital | 2,085 | 2,498 | 3,108 | 3,391 | 1,035 | 2,312 | Upgrade
|
| Book Value Per Share | 7.18 | 7.35 | 7.28 | 7.29 | 5.36 | 6.22 | Upgrade
|
| Tangible Book Value | 6,561 | 6,690 | 6,915 | 6,898 | 4,177 | 4,982 | Upgrade
|
| Tangible Book Value Per Share | 6.01 | 6.13 | 6.34 | 6.26 | 4.06 | 4.78 | Upgrade
|
| Buildings | 1,217 | 1,218 | 1,208 | 1,218 | 946.22 | 957.04 | Upgrade
|
| Machinery | 1,230 | 1,203 | 1,138 | 1,109 | 923.7 | 861.71 | Upgrade
|
| Construction In Progress | 50.62 | 34.35 | 37.6 | 94.13 | 343.78 | 206.02 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.